Home » Topics » Disease categories and therapies » Neurology/psychiatric

Neurology/psychiatric
RSS

Novo Nordisk prepares compounds with high affinity for 5-HT2C receptors

Feb. 25, 1997

Acorda and Elan to collaborate on spinal cord injury treatment

Feb. 24, 1997

Licenses offered for vasospasm therapy

Feb. 24, 1997

NIH seeks licensees for antispasmodic immunotoxin

Feb. 24, 1997

Transdermal buspirone pivotal trials

Feb. 21, 1997

Sanofi Winthrop reveals calpain inhibitors

Feb. 21, 1997

Novel kappa-opioid agonist from Parke-Davis

Feb. 20, 1997

Athena Neurosciences and Lilly extend research collaboration

Feb. 20, 1997

SIBIA Neurosciences initiates clinical trials of antiparkinsonian product

Feb. 20, 1997

Cortex seeks AMPAkine patent approval

Feb. 20, 1997

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for June 1, 2026.
TROP2 ADCs progress into first-line for lung, breast cancers
BioWorld
Multiple updates on TROP2-directed antibody-drug conjugates (ADCs) for lung and breast cancers highlight both progress made and opportunities for improvement for...
News in brief
BioWorld Asia
BioWorld Asia briefs for June 2, 2026
BMS’ mezigdomide doubles PFS in multiple myeloma
BioWorld
Bristol Myers Squibb Co. disclosed in March 2026 that the phase III portion of the seamless phase II/III Successor-2 study testing mezigdomide in combination with...
Breakthrough as GSK’s bepirovirsen clears 19% of chronic hep B infections
BioWorld
GSK plc has announced a breakthrough in the treatment of chronic hepatitis B, reporting a functional cure rate of 19% across two phase III trials of its antisense...